CNBC-TV18 executive editor Shereen Bhan and Archana Shukla reports that Malvinder Singh, while denying all wrong-doing at Ranbaxy, says that Daiichi took months to clinch the deal and the due diligence process was rigourously followed.
first published: May 23, 2013 08:40 pm
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
Live: Will bulls take Nifty to fresh lifetime highs today? | Opening Bell
Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell
